Jammu kashmir terror attack: After the Pahalgam terror attack, India’s action seems to be hovering over Pakistan in many ways. In such a situation, it is being said that there can be shortage of medicines in Pakistan.
According to the report of Geo News, currently Pakistan is dependent on 30 percent to 40 percent of raw materials with drugs, including active pharmaceutical material (API) and many advanced medical products. Pakistan’s Drug Regulatory Authority (DRAP) has confirmed that although no formal notification has been given about the impact of the ban on the drug sector, contingency plans are already prepared.
Finding options in China, Russia and European countries
A senior DRAP official said that after the 2019 crisis, we started preparations for such emergency. Now we are considering alternative routes to meet the needs of our medicine. DRAP is now looking for alternative sources from China, Russia and many European countries.
The agency aims to ensure continuous availability of essential medical supplies including anti-rabies vaccine, anti-stenam, cancer therapy, monoclonal antibodies and other important biological products. Even though the DRAP assures that we have prepared, the internal sources and health experts in the pharma industry have warned that if immediate action is not taken to deal with the ill effects of business suspension, a big challenge can be created.
Medicines come to Pakistan through smuggling
The Ministry of Health has not yet received any official instructions to clarify the status of drug imports, while the government has announced to suspend all trade with India. The drug sector is afraid that interruptions in the supply chain may cause a serious problem in Pakistan. The situation is also serious about the black market of drugs in Pakistan, where unregistered and disarray medicines, of which are of Indian origin, come through smuggling in Pakistan through Afghanistan, Iran, Dubai and even the eastern border.
Appeal to exemption the drug sector from the ban
A delegation of pharmaceutical industry leaders went to Islamabad on Thursday to appeal for exemption from trade ban. Tauqir-ul-Haq, president of the Pakistan Pharmaceutical Manufacturers Association (PPMA), said that we held meetings with DRAP and Ministry of Commerce Ministry officials to discuss the suspension of trade relations. We urged them to exempt the drug sector from the ban, because there are many life -saving products whose raw materials especially come from India.
Also read:
Kailash Mansarovar Yatra brought a big update, know when it will start
